Literature DB >> 21715489

NF-kappaB protects human papillomavirus type 38 E6/E7-immortalized human keratinocytes against tumor necrosis factor alpha and UV-mediated apoptosis.

Ishraq Hussain1, Ikbal Fathallah, Rosita Accardi, Jiping Yue, Djamel Saidj, Ruchi Shukla, Uzma Hasan, Tarik Gheit, Yamei Niu, Massimo Tommasino, Bakary S Sylla.   

Abstract

Constitutive activation of NF-κB signaling is a key event in virus- and non-virus-induced carcinogenesis. We have previously reported that cutaneous human papillomavirus type 38 (HPV38) displays transforming properties in in vitro and in vivo experimental models. However, the involvement of NF-κB signaling in HPV38-induced cell growth transformation remains to be determined. In this study, we showed that HPV38 E6 and E7 activate NF-κB and that inhibition of the pathway with the IκBα superrepressor sensitizes HPV38E6E7-immortalized human keratinocytes to tumor necrosis factor alpha (TNF-α)- and UVB radiation-mediated apoptosis. Accordingly, inhibition of NF-κB signaling resulted in the downregulation of NF-κB-regulated antiapoptotic genes, including cIAP1, cIAP2, and xIAP genes. These findings demonstrate a critical role of NF-κB activity in the survival of HPV38E6E7-immortalized human keratinocytes exposed to cytokine or UV radiation. Our data provide additional evidence for cooperation between beta HPV infection and UV irradiation in skin carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21715489      PMCID: PMC3165856          DOI: 10.1128/JVI.00002-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Apoptosis in proliferating, senescent, and immortalized keratinocytes.

Authors:  V Chaturvedi; J Z Qin; M F Denning; D Choubey; M O Diaz; B J Nickoloff
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

Review 2.  Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway.

Authors:  Y Kfoury; R Nasr; O Hermine; H de Thé; A Bazarbachi
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

3.  Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.

Authors:  Wen Dong; Ulrich Kloz; Rosita Accardi; Sandra Caldeira; Wei-Min Tong; Zhao-Qi Wang; Lars Jansen; Matthias Dürst; Bakary S Sylla; Lutz Gissmann; Massimo Tommasino
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8.

Authors:  Inke Diana Schaper; Gian Paolo Marcuzzi; Sönke Jan Weissenborn; Hans Udo Kasper; Volker Dries; Neil Smyth; Pawel Fuchs; Herbert Pfister
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

5.  Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.

Authors:  D C Duffey; Z Chen; G Dong; F G Ondrey; J S Wolf; K Brown; U Siebenlist; C Van Waes
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

6.  Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling.

Authors:  M van Hogerlinden; B L Rozell; L Ahrlund-Richter; R Toftgård
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

7.  Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.

Authors:  Z Dong; G Greene; C Pettaway; C P Dinney; I Eue; W Lu; C D Bucana; M D Balbay; D Bielenberg; I J Fidler
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

8.  High levels of p105 (NFKB1) and p100 (NFKB2) proteins in HPV16-transformed keratinocytes: role of E6 and E7 oncoproteins.

Authors:  L Havard; S Rahmouni; J Boniver; P Delvenne
Journal:  Virology       Date:  2005-01-20       Impact factor: 3.616

9.  Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.

Authors:  B S Sylla; S C Hung; D M Davidson; E Hatzivassiliou; N L Malinin; D Wallach; T D Gilmore; E Kieff; G Mosialos
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.

Authors:  J J Li; J S Rhim; R Schlegel; K H Vousden; N H Colburn
Journal:  Oncogene       Date:  1998-05-28       Impact factor: 9.867

View more
  12 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization.

Authors:  Erik R Vandermark; Krysta A Deluca; Courtney R Gardner; Daniel F Marker; Cynthia N Schreiner; David A Strickland; Katelynn M Wilton; Sumona Mondal; Craig D Woodworth
Journal:  Virology       Date:  2012-01-28       Impact factor: 3.616

Review 3.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

4.  Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.

Authors:  Djamel Saidj; Marie-Pierre Cros; Hector Hernandez-Vargas; Francesca Guarino; Bakary S Sylla; Massimo Tommasino; Rosita Accardi
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

Review 5.  Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance.

Authors:  Assunta Venuti; Stefan Lohse; Massimo Tommasino; Sigrun Smola
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

Review 6.  The papillomavirus E7 proteins.

Authors:  Ann Roman; Karl Munger
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

7.  Epidermal RelA specifically restricts contact allergen-induced inflammation and apoptosis in skin.

Authors:  Snehlata Kumari; Benjamin Herzberg; Ruth Pofahl; Thomas Krieg; Ingo Haase
Journal:  J Invest Dermatol       Date:  2014-04-16       Impact factor: 8.551

8.  NF-κB-induced KIAA1199 promotes survival through EGFR signalling.

Authors:  Kateryna Shostak; Xin Zhang; Pascale Hubert; Serkan Ismail Göktuna; Zheshen Jiang; Iva Klevernic; Julien Hildebrand; Patrick Roncarati; Benoit Hennuy; Aurélie Ladang; Joan Somja; André Gothot; Pierre Close; Philippe Delvenne; Alain Chariot
Journal:  Nat Commun       Date:  2014-11-04       Impact factor: 14.919

9.  Evolution of malignant plasmacytoma cell lines from K14E7 Fancd2-/- mouse long-term bone marrow cultures.

Authors:  Xichen Zhang; Wen Hou; Michael W Epperly; Lora Rigatti; Hong Wang; Darcy Franicola; Aranee Sivanathan; Joel S Greenberger
Journal:  Oncotarget       Date:  2016-10-18

10.  Effect of Infliximab on the UVB-Induced Apoptosis of Keratinocytes Infected by HPV38 E6/E7.

Authors:  François Aubin; Tarik Gheit; Jean Luc Prétet; Massimo Tommasino; Christiane Mougin
Journal:  ISRN Dermatol       Date:  2013-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.